These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Risk factors and drug interactions predisposing to statin-induced myopathy: implications for risk assessment, prevention and treatment. Chatzizisis YS; Koskinas KC; Misirli G; Vaklavas C; Hatzitolios A; Giannoglou GD Drug Saf; 2010 Mar; 33(3):171-87. PubMed ID: 20158283 [TBL] [Abstract][Full Text] [Related]
4. Neuromuscular complications of statins. Ahn SC Phys Med Rehabil Clin N Am; 2008 Feb; 19(1):47-59, vi. PubMed ID: 18194749 [TBL] [Abstract][Full Text] [Related]
5. Suggested clinical approach for the diagnosis and management of 'statin intolerance' with an emphasis on muscle-related side-effects. Sivashanmugarajah A; Fulcher J; Sullivan D; Elam M; Jenkins A; Keech A Intern Med J; 2019 Sep; 49(9):1081-1091. PubMed ID: 31507054 [TBL] [Abstract][Full Text] [Related]
6. Statins, myalgia, and rhabdomyolysis. Tournadre A Joint Bone Spine; 2020 Jan; 87(1):37-42. PubMed ID: 30735805 [TBL] [Abstract][Full Text] [Related]
7. [Myopathies under therapy with lipid-lowering agents]. Köller H; Neuhaus O; Schroeter M; Hartung HP Nervenarzt; 2005 Feb; 76(2):212-7. PubMed ID: 15609055 [TBL] [Abstract][Full Text] [Related]
8. Management of Statin Intolerance in 2018: Still More Questions Than Answers. Toth PP; Patti AM; Giglio RV; Nikolic D; Castellino G; Rizzo M; Banach M Am J Cardiovasc Drugs; 2018 Jun; 18(3):157-173. PubMed ID: 29318532 [TBL] [Abstract][Full Text] [Related]